Depression Clinical Trials

Showing 2741-2760 of 3,090 trials

Effectiveness of a Web-based Prevention Program for Postpartum Depression

NCT00816725

The original trial will evaluate the effectiveness of a Web-based program in preventing postpartum depression. The site has been modified to provide materials from both conditions.

DepressionPostpartum Depression

University of California, San Francisco1,000 participantsStarted Jan 2009

San Francisco, California, United States

COMPLETEDPhase 1

Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects

NCT01520649

This is a Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Escalation in depressed human subjects study.

Depression

Neuralstem Inc.26 participantsStarted May 2012

Glendale, California, United States

COMPLETEDPhase 3

YAZ Premenstrual Dysphoric Disorder (PMDD) in China

NCT00824187

The purpose of this study is to evaluate the efficacy and safety of YAZ compared to placebo in the treatment of symptoms related to Premenstrual Dysphoric Disorder (PMDD).

Premenstrual Dysphoric Disorder ( PMDD)

Bayer187 participantsStarted Jan 2009

Guangzhou, Guangdong, China • Guangzhou, Guangdong, China • Wuhan, Hubei, China +13 more locations

Effectiveness of a Web-based Prevention Program for Postpartum Depression

Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects

YAZ Premenstrual Dysphoric Disorder (PMDD) in China

Related Searches

The Effect of Mirror Education for Women Undergoing Mastectomy

A Trial of Group Psychotherapy for Veterans and Military Personnel With Post Traumatic Stress Disorder (PTSD)

Web-Based Survey of Pain, Stress and Complementary and Alternative Medicine

Clinical and Biological Characteristics of Psychotic Depression

Automatic Self Transcending Meditation (ASTM) Versus Heart Rate Variability (HRV) Biofeedback in Patients With Late Life Depression (LLD): a Longitudinal Pilot Feasibility Study

Major Depression and Messenger RNAs

Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT

Randomised Placebo-controlled Duloxetine-referenced Efficacy and Safety Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder

Telephone Care as a Substitute for Routine Psychiatric Medication

Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder

Depression Prevention for Pregnant Women on Public Assistance

Care Managers for Perinatal Depression (CMPD)

Open-label Safety Extension Study of 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults

An Open Prospective Trial of IV Ketamine in Suicidal Adolescents

Physician Survey on Monitoring of Patients Treated With Quetiapine

Internetbased Relapse Prevention for Partially Remitted Depression

Probiotics and the Microbiome: Clinical Intervention Trial for Anxiety and Depression